Tri Locum Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-160,660
Closed -$14.2M 75
2023
Q2
$14.2M Buy
+160,660
New +$13.8M 5.26% 7
2021
Q4
Sell
-104,070
Closed -$13M 47
2021
Q3
$13M Sell
104,070
-80,610
-44% -$10.4M 5.18% 9
2021
Q2
$22.9M Sell
184,680
-54,964
-23% -$6.9M 7.5% 4
2021
Q1
$28.3M Buy
239,644
+35,506
+17% +$4.16M 7.02% 4
2020
Q4
$23.9M Buy
+204,138
New +$22.5M 8.68% 3

Other funds holding MDT

Tri Locum Partners's MDT Position: Q3 2023 in Review

Tri Locum Partners sold out of Medtronic (MDT) in Q3 2023, closing a stake of 160,660 shares — an estimated $14.2M sold.

Tri Locum Partners first reported a position in MDT in Q4 2020 and held it in 5 quarters. The position peaked at $28.3M in Q1 2021. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • Tri Locum Partners reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
  • Tri Locum Partners sold 160,660 Medtronic shares in Q3 2023, an estimated $14.2M.
  • Tri Locum Partners first reported a position in Medtronic in Q4 2020 and held it in 5 quarters.
  • Tri Locum Partners's Medtronic position peaked at $28.3M in Q1 2021.
  • 1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Tri Locum Partners's 13F filing for Q3 2023, filed 14 Nov 2023.